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1. Introduction 
Pseudoexfoliation (PXF) syndrome is a pathologic accumulation of abnormal fibrillar 
deposits on various ocular structures and extraocular tissues (Figure 1). It is an age-related 
disorder of the extracellular matrix that may affect up to 20% of people over the age of 60. 
Although the specific synthesis and pathogenesis of PXF syndrome are still unknown the 
concept of an elastotic process has recently been established by the finding of the lysyl 
oxidase-like 1 (LOXL 1) gene as a major risk factor for PXF syndrome and PXF glaucoma 
(Thorleifsson et al., 2007). It was first described by a Finnish ophthalmologist named John 
Lindberg, in 1917 in his doctoral thesis. With the aim of a newly developed slit-lamp, he 
defined the grayish flecks and the changes on the lens and the pupillary margin of the iris in 
50% of patients with chronic glaucoma. 
The reported prevalence rates vary extensively in different populations like: general 
population, persons over a certain age, patients with cataract or glaucoma, patients with 
severe glaucoma. The examiner and the method (mydriasis or not, early stages or not) also 
play an important role in the prevalence. Its prevalence varies considerably between 
countries and even within regions or between ethnic groups within many countries. Low 
rates have been found in Greenland Eskimos (0%), in India (4.2% in patients older than 70 
years), in the eastern part of the United States (5% in patients between 75 and 85 years old), 
in Germany (1.5% in patients 70-79 years of age and 6.3% in those between 80 and 89) and in 
Britain (2% in 70-79 and 5.4% in 80-89) (Vesti & Kivela, 2000). Also in Australia (2.2% in 
older than 40), in Japan (1.24% in older than 40) (Ringvold, 1999) and in Austria (1.7%), in 
Denmark (2%) and in Switzerland (2%) in patients older than 60 years old (Forsius, 1988).  
On the other hand, high frequencies have been reported in Iceland (31.5%), Finland (>20%), 
Saudi Arabia (26.5%), Russia (21.4%), Tunisia (19.1%), all in patients older than 70 years old 
and in Greece (20.1% in ages 70-79 and 46.9% in patients older than 80) (Vesti & Kivela, 
2000). Also, in Sweden (18% in ages 65-74), in Norway (16.9% in older than 65) (Ringvold, 
1999) and in Turkey (18% in older than 60) (Forsius, 1988). In southwestern Greece in a 
cross-sectional study of patients admitted at the hospital for cataract surgery we found the 
prevalence of PXF syndrome to be 27.9% (Andrikopoulos et al., 2009).  
Pseudoexfoliation syndrome has been associated with cataract progression, increased 
intraocular pressure and intraoperative complications like zonular or posterior capsule 
rupture, poorly dilating pupils, vitreous loss and postoperative fibrinoid reaction or 
luxation of intraocular lens implants. It is the most common identifiable cause of open-angle 
glaucoma, the pseudoexfoliation glaucoma. The later is characterized by worse prognosis 
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than primary open angle glaucoma, rapid progression and higher resistance to medical 
therapy. 
 
 
Fig. 1. Pseudoexfoliation material. 
The definite clinical diagnosis of PXF deposits can be made only in the last stages of classic 
PXF (fibers in the two zones) and in the stage of mini-PXF (focal defects in the precapsular 
layer nasal superiorly). Next to the lens PXF deposits are most prominent to the pupillary 
border. Additional subtle clinical signs at the slit-lamp examination include loss of melanin 
from the peripupillary pigment epithelium of the iris, transillumination defects in the 
sphincter area, insufficient mydriasis, posterior synechiae, zonular instability, melanin 
deposition and melanin dispersion (on the structures of anterior segment) after pupillary 
dilation. 
It appears that a variety of epithelial and mesenchymal cells may be associated with 
disordered synthesis of the extracellular fibrillar material in different sites. The intraocular 
material seems to be produced mainly in the pre-equatorial lens epithelium, the 
nonpigmented ciliary epithelium and the iris pigment epithelium and secondarily in the 
corneal endothelium, the trabecular endothelium and by almost all cell types of the iris 
stroma (Ritch & Schlötzer-Schrehardt, 2001). Secondary distribution by the aqueous humor 
is responsible for its passive deposition on the other structures of the anterior segment. The 
extraocular PXF material has been demonstrated electron microscopically in close proximity 
to fibroblasts, smooth and striated muscle cells, and heart muscle cells (Schlötzer-Schrehardt 
et al., 1992a; Streeten et al., 1992). These types of cells are probably involved in its 
production in various visceral organs. 
There are two major theories on the pathogenesis of PXF syndrome. The first links the 
exfoliation fibers to the elastic microfibrils of the elastic system. It describes PXF syndrome 
as a type of elastosis, an elastic microfibrillopathy with excessive production of elastic fiber 
components (Garner & Alexander, 1984; Streeten et al., 1986). The second theory considers 
PXF syndrome to be a generalized disorder of the basement membranes (Dickson & 
Ramsay, 1975), with a variety of basement membrane components to have been recognized 
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in the PXF material (Eagle et al., 1979; Harnisch et al., 1981; Konstas et al., 1990; Kubota et 
al., 1998; Schlötzer-Schrehardt et al., 1992b; Tawara et al., 1996). Growth factors (GFs) and 
particularly Transforming Growth Factor-β1 (TGF-β1), impaired cellular protection system 
with increased cellular and oxidative stress, an imbalance between Matrix 
Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs), 
ischemia/hypoxia, cross-linking process and aggregation of misfolded stressed proteins 
appear to be involved in the pathogenetic concept of this fibrotic disorder with 
accumulation of extracellular material (Gartaganis et al., 2001, 2002, 2005, 2007; Schlötzer-
Schrehardt & Naumann, 2006; Schlötzer-Schrehardt, 2009). 
The exact chemical composition of PXF material remains unknown. It seems to consist a 
complex of glycoprotein/proteoglycan with epitopes of the basement membrane and the 
elastic fiber system. The protein components of PXF material include non-collagenous 
basement membrane elements (such as laminin, nidogen, and fibronectin), epitopes of 
elastic fibers (such as elastin, tropoelastin, amyloid P, vitronectin) and components of elastic 
microfibrils such as fibrillin-1, emilin, microfibril-associated glycoprotein-1, and latent TGF-
β binding proteins 1-2) (Ritch & Schlötzer-Schrehardt, 2001). Other proteins are cross-linking 
enzymes, chaperones, apolipoproteins, glycosaminoglycans, complement proteins, 
proteolytic enzymes and their inhibitors, and cytokines like TGF-β1. Τhe 
glycosaminoglycans and proteoglycans include heparan sulfate proteoglycan, chondroitin 
sulfate proteoglycan, dermatan sulfate proteoglycan, keratan sulfate proteoglycan, and 
hyaluronan (Fitzsimmons et al., 1997; Harnisch et al., 1981; Schlötzer-Schrehardt et al., 
1992b; Tawara et al., 1996). The microfibrillar subunits seem to form a core surrounded by 
an amorphous matrix, which is suggested to represent glycosaminoglycans on the surface of 
the exfoliation fibrils.  
2. Pseudoexfoliation syndrome and cataract formation   
An association between PXF and cataract formation appears to exist. Nuclear cataract and 
secondarily subcapsular cataract are more frequently found in eyes with PXF than in eyes 
without PXF. And opposite, PXF has a higher prevalence in eyes with cataract (Hietanen et 
al., 1992). In a study conducted by the authors the prevalence of cataract in eyes with PXF 
was found 87.4% and in eyes without PXF 79.9%. And opposite, PXF prevalence in eyes 
with cataract was found 24.2% and in eyes without cataract 15.5% (Andrikopoulos, 2009). 
Eyes with PXF have been found with poorer visual acuity and more often lens opacification 
than clinically uninvolved fellow eyes (Puska, 1994). Cataract formation may be related to 
ocular ischemia, aqueous hypoxia, reduced protection against ultraviolet radiation, 
increased growth factor levels and oxidative stress. Ascorbic acid, that plays an important 
role in protecting the lens from ultraviolet irradiation, has been found reduced in the 
aqueous humor of patients with PXF deposits (Koliakos et al., 2003). 
3. Pseudoexfoliation syndrome and cataract surgery 
3.1 Intraocular manifestations of pseudoexfoliation syndrome that predispose to 
surgical complications 
Lens In contrast to the characteristic changes in the anterior capsule which are relatively 
harmless, the pre-equatorial lens epithelium disorders may be associated with dangers for 
the intraocular surgeon. In the area corresponding to the proliferative zone of the epithelium 
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and the zone of zonular anchorage, deposits infiltrate and disrupt the lens capsule and the 
zonular lamella, resulting in separation of the zonules insertion on the capsule surface 
(Schlötzer-Schrehardt & Naumann, 1994). This peripheral region is the only area with active 
production of PXF material by the metabolically active epithelium. These changes are 
hidden behind the iris and thus clinically invisible, but responsible for the instability of the 
zonular attachment.  
Zonules and ciliary body In cases associated with phacodonesis or lens luxation, 
degeneration of zonular attachment sites is usually observed (Schlötzer-Schrehardt & 
Naumann, 1994). Areas of weakness and zonular dehiscence include the zonular fibers 
themselves but also their anchorage sites to the defective basement membranes of the ciliary 
epithelium and lens. Proteolytic-lysosomal enzymes, that have been found within PXF 
material, may also be linked with the zonular disintegration. Zonular instability and 
subsequent laxity of the lens allows anterior lens movement resulting in pupillary or even 
ciliary block, that predispose to angle closure glaucoma. Attacks of angle closure glaucoma, 
because of inferior displacement of the lens, can occur, particularly under miotic therapy. 
Iris Virtually all iris cell types are involved in PXF material production and deposition. 
Clinically PXF iris is characteristically rigid with reduced dilating properties. Dispersion of 
melanin granules, after pharmacological dilation, due to rupture of degenerative posterior 
pigment epithelial cells, may result in acute rise in IOP. Iris stromal vessels, because of 
deposition of fibers in the adventitia, may become obliterated resulting in hypoperfusion 
and iris microneovascularization. Neovascularization may result in microhyphema after 
pharmacologic dilation. PXF ocular ischemia may play a role in cataract formation too. Iris 
vasculopathy may be associated with a chronic breakdown in the aqueous barrier, that may 
manifest as pseudouveitis with posterior synechiae and elevated aqueous flare. Blood-
aqueous barrier dysfunction is greater in eyes with PXF compared to eyes without PXF, after 
intraocular surgery, resulting in a transitory fibrinoid reaction. Posterior synechiae are 
common in PXF eyes due to adherence of the posterior pigment epithelium to the PXF 
coated anterior lens capsule or to miotics that inhibit iris movement.  A combination of PXF 
fibers deposition in the stroma and muscle tissue with vascular disorders leads to hypoxia 
(Repo et al., 1995) and tissue degeneration that result in reduced dilating properties of iris 
(Asano et al., 1995). Even without mydriatics, the pupil in PXF eyes may be smaller 
(suggesting a defective dilator muscle or reduced sympathetic innervation).  
Trabecular meshwork The deposits of PXF material and probably the melanin pigment 
throughout the trabeculum and the degenerating changes of the juxtacanalicular tissue 
beneath the inner wall of Schlemm’s canal are the major mechanisms of PXF open-angle 
glaucoma (Ringvold & Vegge, 1971; Schlötzer-Schrehardt & Naumann, 1995). The 
pathologic alterations of Schlemm’s canal include narrowing, fragmentation and obstruction 
in advanced cases. Apart from the obstruction to trabecular outflow, increased aqueous 
protein levels (due to persistent blood-aqueous barrier breakdown), an impaired ocular and 
retrobulbar perfusion and disorder of elastic tissue of the lamina cribrosa (Netland et al., 
1995), have also been proposed. It is well known that PXF is the most common identifiable 
cause of open-angle glaucoma (Ritch, 1994a). It is also associated with a higher incidence of 
narrow angles (Herbst, 1976; Ritch, 1994b). 
Cornea The corneal endothelium shows focal degeneration, phagocytosis of melanin 
granules and PXF fibers production. Central corneal thickness has been found greater in 
eyes with PXF. These changes together with a reduced endothelial cell density may lead to 
an irregular thickening of the Descement membrane. The dysfunctional endothelium in PXF 
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eyes increases the risk of corneal endothelial decompensation with normal or after moderate 
rises in intraocular pressure (IOP), for example after mydriasis or after cataract surgery. 
3.2 Preoperative considerations  
Recognition of PXF material is critical for reducing operative complications. The classic 
pattern of three distinct zones of PXF material on the anterior lens surface represents a very 
late stage of the disease. In early stages a diffuse pre-capsular layer of microfibers (“early 
PXF”) can be observed on the entire surface of the anterior lens capsule. Later focal defects 
in the midperipheral zone usually superonasally (“mini PXF”) may alert the 
ophthalmologist. The importance of a dilated pupil and the comparison with the fellow eye 
have been emphasized by a number of authors. Iris changes like transillumination defects, 
melanin pigment liberation associated with pupil dilation, poor mydriasis or asymmetric pupil 
sizes and circular posterior synechiae are useful signs. Other early clinical signs are: PXF or 
melanin deposition on the anterior chamber structures (especially the trabecular meshwork), 
marked asymmetry of IOP or marked IOP rise after pupillary dilation, phacodonesis and 
atypical cornea guttata. In eyes with mature cataract it is mandatory to look carefully for PXF 
deposits as they may have the same colour with the grey-white cataract.  
The complication rates of cataract extraction in PXF syndrome are higher compared to 
control. Phacoemulsification in PXF eyes is associated with increasd rates of capsular and 
zonular tears and vitreous loss (Drolsum et al., 1993; Shingleton et al., 2003). On the other 
hand, recent studies around the world have shown no statistically significant difference in 
complication rates during phacoemulsification of PXF eyes (Akinci et al., 2008; Dosso et al., 
1997; Hyams et al., 2005) than earlier studies that showed up to a 10-fold increase. 
Phacoemulsification performed by experienced surgeons, in combination with advanced 
technologies and devices, have decreased the risks. It is reported, in recent studies, that a 
thorough cataract consideration is important, in eyes with PXF syndrome, as it can minimize 
the risk for complications (Belovay et al., 2010; Drolsum et al., 2007; Shingleton et al., 2009; 
Tanhehco & Chen, 2010). 
Zonule weakness The signs of zonular weakness include phacodonesis, lens subluxation, 
narrow iridocorneal angle, zonule dialysis and iridodonesis. Iridodonesis is best assessed 
prior to dilation, while phacodonesis, lens subluxation and zonule dialysis after maximum 
mydriasis. A shallow or hyper-deep anterior chamber may consist an indirect sign of zonule 
instability and lens displacement. A central anterior chamber depth less than 2.5 mm has 
been reported to increase the risk for surgical complications 5-fold in PXF eyes (Küchle et al., 
2000). An asymmetry in anterior chamber depth or significant differences in refraction 
between the two eyes may be indicative of a subluxated lens. The increased cataract density, 
the increasing age and the reduced pupil size are indirect clinical predictors of zonule 
instability, while the amount of PXF material does not seem to be a predicting factor 
(Moreno et al., 1993). Ultrasound biomicroscopy can be useful to check the zonule status like 
infiltration of PXF fibrils, fragmentation or zonule loss. Zonular fragility has been associated 
with a 3 to 10-fold increased risk of zonular rupture and lens dislocation and a 5-fold 
increased risk of vitreous loss (Schlötzer-Schrehardt & Naumann, 2006).  
Small pupil Poor pupil dilation may limit the size of the capsulorhexis. A small 
capsulorhexis often leads to increased and traumatic forces on the zonular apparatus and 
increased risk for capsular tear and postoperative capsule phimosis. The increased difficulty 
in extracting nuclear material from the capsular bag, due to a small pupil, can also lead to 
iris trauma and intraoperative bleeding. 
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It is also important to check carefully the corneal endothelial status, as reduced endothelial 
cell counts increases the risk of corneal endothelial dysfunction or decompensation. 
3.3 Intraoperative considerations 
Many surgical approaches have been used to avoid corneal failure and to manage a small 
pupil and zonular weakness. 
Corneal endothelium Dispersive ophthalmic viscosurgical devices are helpful to adhere, 
coat and protect the cornea. Cohesive ophthalmic viscosurgical devices can help to dilate a 
small pupil and to maintain the anterior chamber (Shingleton et al., 2009). Overinflating the 
anterior chamber with viscoelastics should be avoided as it may cause undue stress on the 
zonules. 
Small pupil In phacoemulsification it is not needed to extrude the nucleus through a full 
dilated pupil as in extracapsular cataract extraction. However, as PXF eyes respond poorly 
to mydriatics many strategies are frequently required intraoperatively. Pharmacologically, 
nonsteroid anti-inflammatory drops in combination with mydriatics can help to expand the 
pupil (Keates & McGowan, 1984). Mechanical enlargement of the pupil includes stretching, 
cohesive ophthalmic viscosurgical devices, release of posterior synechiae, sphincterotomy as 
well as iris hooks and pupil dilator rings. Special iris hooks (Figure 2a) can be used to allow 
visualization of the peripheral capsule and to release posterior synechiae. Bimanual 
stretching with Y-hooks, the Beehler pupil dilator, iris retractor hooks and pupil dilator 
polymethyl methacrylate rings have all been shown to be equally effective (Akman et al., 
2004). Other pupil expansion devices like the Malyugin ring (Figure 2b), the Perfect pupil 
expansion device and the Graether pupil expander have also been used. However, pupil 
stretching and cutting should be avoided in patients predisposed to floppy-iris syndrome 
(Chang et al., 2008). Also, pupil mechanical dilation may lead to iris injury and hyphema, 
pigment release, postoperative inflammation and sometimes to a permanently dilated pupil.  
 
 
Fig. 2. a. Iris hook, b. Malyugin ring. 
Zonule weakness When the zonules are loose a capsule tension ring (CTR) placed within an 
intact capsular bag may be useful (Figure 3a). It provides capsular bag expansion and 
supports the part of zonule instability, distributing the zonule tensions from the weakened 
zonules onto the remaining zonules. In this way it can provide buttress for the entire 
capsule-zonular apparatus (Menapace et al., 2000). It is reported that a CTR can center a 
mildly subluxed lens (equal or less than 4 hours zonulopathy and/or mild phacodonesis) 
(Hasanee & Ahmed, 2006) but does not prevent the progressive zonulopathy and the 
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following decentration in the presence of PXF material (Ahmed et al., 2005a). Also, it should 
not be used in cases of anterior or posterior capsular tear. Although a CTR can be implanted 
at any time after performing the capsulorhexis, most surgeons propose delaying 
implantation. It was found that CTR implantation before nucleus extraction gave increased 
capsular torque and displacement compared to implantation after the nucleus had been 
extracted (Ahmed et al., 2005b). Although some surgeons propose the use of a CTR in all 
PXF cases, regardless of whether zonule instability is present, the implantation can be 
hazardous and should better be performed only in cases of zonule instability, as it may 
create capsule and zonule trauma or entrapment of cortex behind it (Ahmed et al., 2005b). 
Regardless of these limitations, a CTR implantation has been found to reduce intraoperative 
complications in PXF cases and to decrease postoperative IOL decentration and tilt (D.-H. 
Lee et al., 2002). Lower rate of intraoperative zonular separation, posterior capsular rupture 
and increased rate of intraocular lens (IOL) fixation in the capsular bag have also been 
reported in PXF eyes with CTR implantation compared to controls (standard 
phacoemulsification) (Bayraktar et al., 2001).  
In more advanced cases of profound zonule fragility a modified CTR, with a single or 
double eyelet for suture fixation to the sclera in areas of weakness, should be considered 
(Cionni & Osher, 1998) (Figure 3b). Capsule either iris retractors placed at the edge of 
capsulorhexis can be effective in holding capsulorhexis in place during phacoemulsification. 
They can also provide support for the capsulozonular complex (V. Lee & Bloom, 1999; 
Santoro et al., 2003). In advanced cases of profound zonule instability a capsule tension 
segment (CTS) can be useful (Figure 3c). The capsule tension segment serves as retracting 
apparatus and supporting stent for the capsular bag during phacoemulsification (Hasanee et 
al., 2006). It has an eyelet that can be used for suture fixation to the sclera in areas of 
weakness providing postoperative stability and good centration of the IOL/capsular bag 
complex. Unlike the larger CTR and modified CTR, the CTS can be positioned 
atraumatically and safely in the presence of an anterior or posterior capsule tear provided 
the CTS is not positioned within the tear itself. One or two CTR devices can be used 
simultaneously too. 
 
 
Fig. 3. a. Capsule Tension Ring, b. modified Capsule Tension Ring, c. Capsule Tension 
Segment. 
If despite the use of all the above devices intraoperative subluxation of lens fragment or 
capsular bag complex occur, the technique should be modified. In these cases most capsule 
tension devices are contraindicated and the available options include elevating the 
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remaining lens into the anterior chamber for anterior phacoemulsification or conversion to 
extracapsular or modified intracapsular cataract extraction. If there is a deep vitreous 
dislocation, pars plana vitrectomy and lensectomy are preferred. Posterior chamber lens 
may also be placed in the ciliary sulcus, even in the presence of small capsular tears 
providing sufficient support exists. Otherwise, an angle-supported IOL, an iris-claw IOL or 
an IOL fixed to the sclera wall may be mandatory (Dick & Augustin, 2001). An angle-
supported anterior chamber IOL should probably be avoided in cases of eyes with glaucoma 
or corneal endothelial cell abnormalities (Drolsum, 2003).   
Surgical technique In phacoemulsification the rate of intraoperative complications in PXF 
eyes is significantly lower than in extracapsular cataract extraction (ECCE) and seems to be 
related to zonular and not to capsule weakness (Shingleton et al., 2003). Small incision, less 
tension on the capsule and the zonules, less anterior chamber depth fluctuations are some of 
the advantages provided by the phocoemulsification, that have increased the safety of 
cataract surgery. On the other hand, the increased force needed to extrude the lens through 
a small pupil and the previous can-opener or envelope techniques with the increased risk of 
posterior capsule rupture may explain the higher frequency of intraoperative complications 
in ECCE. 
When zonule instability is suspected, overinflating the anterior chamber with viscoelastics 
should be avoided. Also, avoidance of excessive fluctuations in anterior chamber pressure 
and gentle manipulation of the lens in phacoemulsification are recommended. Maintenance 
of anterior chamber avoids vitreous prolapse around the capsular bag. Small incision 
surgery, controlled paracentesis and adequate hydrodissection are some more useful 
strategies.  
The continuous circular capsulorhexis (CCC) should be neither too small, nor too large. The 
ideal size is 5-5.5mm in diameter. A small CCC may lead to increased stress to a loose 
zonule during manipulation of the lens and to anterior capsular phimosis. A large CCC may 
preclude the use of capsule devices and may be suboptimal for IOL fixation. In PXF cases 
with zonule instability, CCC initiation and spread of the capsular tear may be difficult, as 
countertraction is decreased. A sharp needle puncture, a CCC forceps or a bimanual 
technique with a micrograsper and a sharp tipped instrument can help in CCC initiation. 
Hooks or capsule retractors at the cut edge of the CCC can help address the spread of the 
capsule tear (Shingleton et al., 2009). Capsule staining (trypan blue) may be helpful allowing 
for visualization of all capsular layers in cases of capsule-splitting phenomena in which 
multiple layers of a split capsule may be raised (Jacobs et al., 2006). 
Adequate hydrodissection allows unimpeded rotation of the nucleus and facilitates cortex 
removal (Vasavada et al., 2002). The procedure has to be performed gently as an aggressive 
injection of fluid may lead to further downward stress and zonular weakness. Alternatively, 
the entire nucleus should be hydrodissected and luxated anteriorly for supracapsular 
phacoemulsification (Drolsum et al., 2007). The choice of IOL does not differ much between 
eyes with PXF and eyes without PXF. So, none of the common IOL materials seem to be 
superior to the others (Wagoner et al., 2003). Plate-haptic PC IOLs, accommodating IOLs, 
multifocal IOLs and aspheric IOLs are associated with a higher risk of subluxation or 
phimosis. Although most foldable PC IOLs are reasonable options in eyes with PXF, the 
slower unfolding acrylic PC IOLs may provide additional control and minimize zonule 
stress during insertion (Shingleton et al., 2009). Acrylic IOLs also seem to cause less anterior 
capsular opacification than silicone ones (Werner et al., 2000). 
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Despite the advances in phacoemulsification power modulation and fluidics, PXF eyes 
continue to have an increased risk of capsule injury particularly from the 
phacoemulsification tip and instruments. Signs of capsular bag collapse include infolding of 
the peripheral posterior capsule, collapse of the capsule equator or visualization of the 
capsule fornix (Belovay et al., 2010). Working in the safe central zone of the anterior 
chamber is proposed. Adequate hydrodissection as well as the use of viscodissection to 
separate cortex from the capsule facilitate cortex removal (Shingleton et al., 2009).  
3.4 Postoperative considerations 
After surgery frequent follow-up examinations are important as early and late postoperative 
complications may occur more frequently in eyes with PXF material. In the early period 
after cataract surgery the main complications include inflammation, keratopathy and IOP 
spikes while in the long term posterior capsule opacification, anterior capsule contraction 
(phimosis) and IOL decentration. 
Inflammation On the basis of blood-aqueous barrier dysfunction intense and/or prolonged 
postoperative inflammation, increased aqueous flare, fibrinoid reaction, posterior synechiae, 
IOL deposits, anterior capsule contraction and macular edema are more frequent in eyes 
with PXF. However, advances in phacoemulsification have reduced dramatically the risk of 
an inflammatory response. PXF eyes with glaucoma have been reported to have increased 
risk for macular edema after phacoemulsification (Yüksel et al., 2008). Iris trauma, which is 
more common in PXF eyes, has been associated with higher rates of macular edema too 
(Gulkilik et al., 2006).  
Intraocular pressure The presence of trabecular outflow and blood-aqueous barrier 
alterations results in an increased risk of early postoperative IOP elevation, particularly in 
patients with preexisting glaucoma (Pohjalainen et al., 2001; Shingleton et al., 2008). 
Postoperative IOP spikes should be prevented through careful aspiration of viscoelastic 
material at the end of the surgery procedure, and meticulous monitor IOP, and use 
prophylactic ocular hypotensive agents, at least in high-risk patients.  
Several studies demonstrate a reduction of IOP in glaucomatous eyes after cataract surgery 
with IOL implantation (Handa et al., 1987; Shingleton et al., 1999). It has been reported that 
the IOP reduction is even greater in PXF eyes and it may be explained by a greater outflow 
improvement, as previously deposited PXF material is expeditiously cleared by the high 
flow states during phacoemulsification and irrigation/aspiration (Shingleton et al., 2003). 
Eyes with higher preoperative IOP and/or narrow angles tend to have greater IOP 
reduction after cataract surgery (Issa et al., 2005; Poley et al., 2008). However, these 
conclusions have been argued by another study that found no difference in IOP reduction 
after cataract surgery between non-glaucomatous eyes with and without PXF (Pohjalainen 
et al., 2001).  
Keratopathy The endothelial cell count is reduced and mean endothelial cell area enlarged 
in exfoliative eyes, predisposing some of them to develop early corneal endothelial 
decompensation even with only moderate rises in IOP or after cataract surgery (Naumann & 
Schlötzer-Schrehardt, 2000). PXF is reported to have a negative influence on endothelial cell 
loss during cataract surgery (Kaljurand & Teesalu, 2007). Working in a safe distance from 
the cornea and adequate viscoelastic can help to protect the endothelial cells during surgical 
maneuvers.  
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Late intraocular lens problems Secondary cataract has been found increased significantly in 
PXF eyes than in controls (Küchle et al., 1997). This increase may be related to a persistent 
breakdown in the blood-aqueous barrier, hypoxia of the anterior chamber, cortical remnants 
and a compromised capsule-zonular complex leading to posterior capsular folds with 
subsequent facilitated migration of lens epithelial cells (Drolsum et al., 2007). Now that 
phacoemulsification is a standard procedure and IOL material is improved, postoperative 
posterior capsule opacification, corneal decompensation and inflammation, even in PXF 
eyes, are rare. 
Even with uneventful phacoemulsification late in-the-bag IOL tilt or dislocation may occur 
many years postoperatively. Age, capsule contraction/phimosis, instability of the blood-
aqueous barrier, surgical trauma to the zonules or postoperative trauma and progressive 
zonular disintegration have been proposed to contribute to the process (Gimbel et al., 2005; 
Gross et al., 2004; Jehan et al., 2001; Kato et al., 2002). PXF syndrome has been reported in 
>50% of all late in-the-bag IOL dislocations (Breyer et al., 1999). The mean time of the late 
subluxation of the IOL-capsular bag complex was 8+ years (range 9 months to 17 years) 
(Jehan et al., 2001). If the IOL optic remains in the pupillary area any intervention can be 
postponed. However, it is usually preferable to intervene surgically as long as an anterior 
approach is still possible. The options are to either reposition or exchange the IOL. We can 
reposition and suture the IOL to the sclera or to the iris. Otherwise, we have to exchange the 
IOL with an angle-supported anterior chamber (AC) IOL (Drolsum et al., 2007). If a 
dislocation far posteriorly of the IOL-capsule complex occurs, a vitreoretinal approach 
should be combined.  
Anterior capsule contraction/phimosis can lead to postoperative IOL subluxation and 
dislocation (Hayashi et al., 1998). Age, blood-aqueous disorder, PXF material, retained 
cortex, IOL material, zonular weakness and a small CCC can lead to increased capsular 
shrinkage (Gimbel et al., 2005; Kato et al., 2002; Kimura et al., 1998; Werner et al., 2000). A 
neodymium: YAG laser radial anterior capsulotomy or a surgical release of the centripetal 
traction of the anterior capsule and zonules should be performed to treat phimosis.  
We studied retrospectively nine patients (ten eyes) with PXF syndrome and late 
spontaneous dislocation of the bag-IOL complex. All patients had undergone uncomplicated 
cataract extraction with posterior chamber IOL implantation 4 to 17 years ago (mean 8.5) by 
the same surgeon (SPG). In one patient IOL dislocation occurred in both eyes approximately 
four months apart. Five surgeries had been performed by the extracapsular cataract 
extraction while in five cases a standardized surgical technique for phacoemulsification had 
been used. A CCC measuring approximately 5.0 to 5.5 mm in diameter had been made 
using forceps. In all cases surgical management included dislocated IOL removal and 
anterior chamber IOL implantation. Five cases underwent 3-port pars plana vitrectomy and 
five underwent anterior vitrectomy. Of the ten explanted IOLs, two were found to be one-
piece polymethylmethacrylate (PMMA) posterior IOLs, one a three-piece PMMA IOL with 
polypropylene haptics, four were three-piece acrylic IOLs, two three-piece acrylic IOLs and 
one a silicone lens; the IOLs’ overall length was 13.0 mm. The explanted IOLs underwent 
microscopic examination and were found to be intact, encased in the capsular bag. In six 
eyes visual acuity improved, in three eyes remained stable, and in one eye was found to be 
deteriorated after 24 months of follow-up, due to the development of age related macular 
disease. In our series, we observed that in five cases where an anterior CCC had been 
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performed, a circumferential anterior capsular overlap of the optic edge was found to be at 
least for 1 mm wide of the 6.0 mm optic zone of the dislocated IOL. Conversely, in cases 
where a can-opener capsulotomy had been made, the edge of the anterior capsule remnant 
was localized outside the edge of the optic part of the IOL. When comparing the cases of 
capsulorhexis to the cases of capsulotomy with regard to the interval between cataract 
surgery and IOL dislocation, we observed that in four cases of can-opener capsulotomy 
dislocation occurred much later (10-17 years) than in the cases of CCC (4-7 years). The 
earlier (4 years) IOL dislocation in an eye with a can-opener capsulotomy may be attributed 
to the co-existence of retinitis pigmentosa and PXF in the same patient that may 
accumulatively have contributed to zonular instability. In the can-opener capsulotomy 
patients both loops of the one-piece PMMA lenses may suggest that the retentive memory of 
the haptics provide stronger resistance to capsule contraction. The long-term dislocation in 
patients with one-piece PMMA IOLs could demonstrate that this type of IOL may also 
function as a capsular tension ring that stabilizes the capsular bag via a centrifugal tension 
on the capsular fornices.  
The aforementioned considerations related to cataract surgery in PXF eyes are summarized 
in Table 1. 
 
Intraoperative Postoperative 
Corneal endotheliopathy 
Small pupil  
Zonule weakness  
Anterior chamber depth disorders  
Posterior capsule dehiscence 
Vitreous prolapse  
 
Fibrinoid reaction 
Aqueous flare  
Posterior synechiae 
IOL deposits 
Macular edema 
Postoperative pressure spikes 
Corneal edema   
Anterior capsule contraction (phimosis)  
Secondary cataract  
IOL subluxation/dislocation 
 
Table 1. Intraoperative and postoperative considerations in cataract surgery in PXF eyes. 
4. Conclusion  
PXF syndrome may cause a spectrum of serious ocular and surgical complications. The 
problems related to cataract surgery are mainly initiated by zonular instability and, to some 
degree, by insufficient pupillary dilation. Awareness of the structural and functional 
features of this disorder may help avoid or minimize most of them.  The early recognition of 
the syndrome in addition to advanced phacoemulsification techniques and associated 
surgical devices have increased the percentage of operative success. Through careful 
consideration with preoperative preparation, surgical awareness and postoperative follow 
up favorable outcomes can be achieved in cataract surgery. 
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